Regenerating Cartilage.
Restoring Motion.
OsteoChon™ is a patent-pending biomimetic hydrogel implant that regenerates true hyaline cartilage and subchondral bone within 12 weeks, an outcome no currently approved, scalable product achieves.
The Problem
Osteochondral defects have no reliable long-term solution
Articular cartilage has limited self-repair capacity. Microfracture, the dominant first-line treatment, produces inferior fibrocartilage that deteriorates within 2–5 years. ACI/MACI requires multi-stage procedures and specialized infrastructure.
Millions of patients worldwide face progressive joint degeneration with no regenerative option that is both effective and scalable.
OsteoChon™ implant: knee osteochondral defect repair